Henry O. Gosebruch
CIK: 0001659625
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Gosebruch Henry O
Gosebruch Henry O (SEC CIK 0001659625) files insider reports with the SEC as Director of ANI PHARMACEUTICALS INC (ANIP) and Director of ACELYRIN, Inc. (SLRN).
Signal8 holds 3 ownership filings by Gosebruch Henry O (1 Form 3, 2 Form 4), filed between May 23, 2025 and Aug 27, 2026. Those filings report 2 transactions, from May 21, 2025 to Aug 19, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Gosebruch Henry O's filings is in PRINCETON, NJ.
Recent filings by Gosebruch Henry O
Other insiders filing for ANI PHARMACEUTICALS INC (ANIP)
- CAREY STEPHEN P., SVP & CFO
- Lalwani Nikhil, PRESIDENT & CEO
- Cook Meredith, SR. VP, GENERAL COUNSEL & SEC.
- Thoma Jeanne, Director
- Gutwerg Ori, SVP, GENERICS
- TANNENBAUM RENEE P, Director